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The session entitled Immunity, Atherogenesis and Vascular Function was presented as 
part of an ISN Forefronts Symposium, organized by the International Society of 
Nephrology (ISN) and held in in Shenzhen, China, 22-25 October 2015. The goal of the 
symposium was to review, update, and exchange current knowledge and ideas on the 
pathophysiology of hypertension, vascular injury, atherogenesis, and immune regulation. 
The symposium brought together cardiovascular physiologists, nephrologists, and 
immunologists to promote exploration of new and innovative areas in research, as well as 
to encourage new and wider cross-disciplinary collaborations. 
 
Dr Andrew Newby’s review, based on his lecturer at the ISN symposium, discusses how 
metalloproteinase from macrophages cause atherosclerotic plaque rupture and myocardial 
infarction (Newby et al. 2016). Macrophages are present at all stages of human and 
experimental atherosclerosis. Although widely assumed that the M1 pro-inflammatory 
state of macrophages can promote plaque rupture and lead to myocardial infarction, the 
evidence in support of this is only slowly accumulating. Moreover, the important 
mediators of macrophage activation are uncertain, which is a barrier to the development 
of appropriate treatments (Stoger et al. 2012). In his presentation and review, Dr Newby 
highlights that plaque rupture and myocardial infarction are most likely the result of a 
‘perfect storm’ caused by the synergistic local effects of multiple inflammatory mediators 
acting together in a hypoxic environment combined with the loss of anti-inflammatory 
factors that are responsible for an excess of matrix metalloproteinase (MMPs) over tissue 
inhibitors of MMP (TIMPs) expression. Dr Newby goes on to critically appraise new data 
pointing to the relative importance of foam cell formation as a result of lipid 
accumulation, and the role of acquired and innate immunity, and discusses the limitations 
of identifying precise mediators in human atherosclerosis and in animal models. While 
MMP and TIMP are regulated divergently in human and mouse macrophages, production 
of matrix degrading enzymes is a key feature connecting macrophage activation to plaque 
instability. Inflammatory mediators work through activator protein-1 and nuclear factor-B 
signalling pathways to regulate different MMP and TIMP expression levels. Dr Newby 
also reviews transcriptional and epigenetic regulation of protease production, together 
with recent evidence from population genetics that supports their importance. 
Furthermore, he addresses prospects for new therapies targeted at macrophage activation 
or its consequences to prevent strokes and myocardial infarctions. 
 
    Dr Zhiming Zhu provides an overview of the role of transient receptor potential (TRP) 
channels in the pathogenesis of hypertension and metabolic vascular damage (Zhu et al. 
2016), also based on his ISN symposium lecure. It is well documented that intracellular 
Ca2+ ([Ca2+]i) homeostasis is important for vascular function and blood pressure 
regulation, as well as for hormone secretion. Recently, TRP channels have gained 
attention in the field of hypertension and metabolic disorders research because of their 
unique roles in controlling [Ca2+]i concentration and vascular function. Mammalian TRP 
channels can be divided into six subfamilies, including TRP canonical (TRPC), TRP 
vanilloid (TRPV), TRP melastatin (TRPM), TRP mucolipin (TRPML), TRP ankyrin 
(TRPA) and TRP polycystin (TRPP). Dr Zhu and his colleagues found an increase in 
TRPC3 and TRPC5 channel protein expression linked to an increase in the 
gadolinium/calcium-influx ratio through TRPC channel activities in the monocytes and 
the vasculature, which are important for an elevation in blood pressure. In contrast, 
activation of TRPV1 and TRPM8 cause  vasodilatation and a lowered blood pressure 
(Zhu et al. 2011). Activation of TRPV1 by capsaicin elicits release of NO from 
endothelium and vasodilatation, which is inhibited by the TRPV1 antagonists. In addition, 
TRPM8 activation by menthol attenuates vasoconstriction and lowers blood pressure. 
These findings suggest a functional equilibrium among different TRP channels subtypes 
that play a critical role in maintaining vascular function and normal blood pressure 
control. Indeed, Dr Zhu propose’s an imbalance in TRP channel function as a new 
underlying mechanism for hypertension (Liu et al. 2014), which may facilitate the design 
of new therapeutics for hypertension and associated vascular damage. 
 
    In conclusion, these review articles provide a useful and timely update in the field of 
applied vascular biology that should encourage further study on the wider interactions of 
immunity, atherogenesis, and vascular function. 
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